Greenwich LifeSciences, Inc. - Common stock (NQ:GLSI)

16.91 -0.07 (-0.41%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Greenwich LifeSciences, Inc. - Common stock

< Previous 1 2 3 4 Next >

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session ↗

June 28, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Greenwich LifeSciences to Resume Stock Repurchase Program

May 23, 2022

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial & ASCO Meeting

May 23, 2022

From Greenwich LifeSciences, Inc.

Via Business Wire

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

69 Biggest Movers From Yesterday ↗

June 10, 2022

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.

Via Benzinga

Greenwich LifeSciences to Participate in Upcoming Jefferies, Wainwright, ASCO and BIO International Conferences

April 20, 2022

From Greenwich LifeSciences, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

Greenwich LifeSciences Presents Phase IIb Data, Published at AACR 2022, Further Supporting the Role of GP2 in Preventing Metastatic Breast Cancer

April 19, 2022

From Greenwich LifeSciences, Inc.

Via Business Wire

Recession Fears are Creating a Golden Opportunity for Biotech Stocks ↗

April 08, 2022

Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 23, 2022

Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the...

Via Benzinga

Greenwich LifeSciences to Present at 2022 BIO CEO & Investor Conference

February 03, 2022

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences Provides Update on Upcoming Phase III Clinical Trial, FLAMINGO-01

February 01, 2022

From Greenwich LifeSciences, Inc.

Via Business Wire

78 Biggest Movers From Friday ↗

February 14, 2022

Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...

Via Benzinga

3 Stocks Insiders Are Buying on Market Turbulence ↗

January 27, 2022

When insiders buy a stock, you should take it as a sign that they think good news is about to come out. Here are three to watch closely.

Via InvestorPlace

62 Biggest Movers From Yesterday ↗

February 11, 2022

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 42.8% to close at $3.07 on Thursday following the company's recent uplisting to the Nasdaq....

Via Benzinga

Greenwich LifeSciences to Implement Stock Repurchase Program for up to $10 Million & to Extend Lock-up of Insiders for an Additional 1 Year

January 24, 2022

From Greenwich LifeSciences, Inc.

Via Business Wire

65 Biggest Movers From Yesterday ↗

January 25, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...

Via Benzinga

Greenwich LifeSciences CEO Participates in TD Ameritrade Interview to Discuss 2021 SABCS Poster

December 15, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences Reveals 5-Year Data for GP2 Immunotherapy In Breast Cancer Settings ↗

December 09, 2021

Greenwich LifeSciences Inc (NASDAQ: GLSI) has published new GP2 Phase 2b trial data. The trial enrolled HER2 positive patients, who received a standard course of...

Via Benzinga

Greenwich LifeSciences Announces Presentation of 5 Year Data for GP2 Phase IIb Clinical Trial, Revealing Potential For New T Cell Platform Technology

December 09, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences to Participate in Multiple Interviews and Conferences

December 08, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences Expands Role of Industry Expert Dr. F. Joseph Daugherty to Include Medical Monitor for its Upcoming Phase III Clinical Trial

December 07, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences Announces Commencement of the First Commercial Line Filling of GP2

December 06, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

58 Biggest Movers From Friday ↗

December 06, 2021

Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30. IO Biotech, Inc. (NASDAQ: IOBT) shares...

Via Benzinga

Greenwich LifeSciences CEO Interview to Air on Bloomberg U.S. on the RedChip Money Report

November 18, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences to Participate in Jefferies’ 12th Annual London Healthcare Conference

November 17, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences Announces Acceptance of Two Posters at Upcoming 2021 SABCS Breast Cancer Conference

November 11, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences Provides Clinical Update on Upcoming Phase III Clinical Trial, FLAMINGO-01

November 10, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences Provides Updated Corporate Presentation and Webcasts

November 09, 2021

From Greenwich LifeSciences, Inc.

Via Business Wire

The Moonshot Investor: The Insider Track Strategy ↗

October 08, 2021

Excerpts of this article were originally published on October 4 and 18, 2021, as part of Tom Yeung's Moonshot Investor series. Investors interested in

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.